telbivudine has been researched along with Recrudescence in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YM; Deng, H; Gao, ZL; Lin, CS; Mei, YY; Peng, L; Xie, C; Xie, DY; Xu, WX; Zhang, Q; Zhao, ZX; Zhu, X | 1 |
| Alteri, C; Andreoni, M; Angelico, M; Cento, V; De Sanctis, GM; Gubertini, G; Micheli, V; Parruti, G; Perno, CF; Pollicita, M; Romano, S; Salpini, R; Sarrecchia, C; Svicher, V; Visca, M | 1 |
| Chan, HL; Chan, HY; Chim, AM; Lo, AO; Tse, CH; Wong, GL; Wong, VW | 1 |
| Guo, SH; Sandeep, KK; Zhang, DZ; Zhang, QF; Zhang, W | 1 |
| Chen, DB; Chen, YM; Gao, ZL; Huang, ZL; Liu, J; Lu, CR; Xie, DY; Zhu, RH | 1 |
| Calise, F; Cuomo, O; DiCostanzo, G; Lanza, AG; Perrella, A; Pisaniello, D | 1 |
| Akarca, US; Bademkiran, F; Duman, S; Ersoz, G; Gunsar, F; Karasu, Z; Kose, T; Ozutemiz, O; Sozbilen, M; Turan, I; Yapali, S | 1 |
| Chen, CR; Chen, L; Huang, HJ; Pan, HY; Tong, YX; Yan, J; Yang, DH | 1 |
| Amato, G; Calise, F; Cuomo, O; Dicostanzo, G; Lanza, AG; Marcos, A; Perrella, A; Pisaniello, D; Santaniello, W | 1 |
1 trial(s) available for telbivudine and Recrudescence
| Article | Year |
|---|---|
[Clinical observations of sequential interferon therapy following complete response to telbivudine treatment in chronic hepatitis B patients].
Topics: Adult; Female; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Recurrence; Telbivudine; Thymidine; Treatment Outcome; Viral Load; Young Adult | 2013 |
8 other study(ies) available for telbivudine and Recrudescence
| Article | Year |
|---|---|
48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse.
Topics: Adenine; Adult; Antiviral Agents; Female; Follow-Up Studies; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Nucleosides; Organophosphonates; Outpatients; Prognosis; Prospective Studies; Recurrence; Risk Factors; RNA, Viral; Telbivudine; Time Factors; Treatment Outcome; Withholding Treatment | 2018 |
Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.
Topics: Adenine; Adult; Antiviral Agents; Cohort Studies; DNA, Viral; Drug Resistance, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Recurrence; Telbivudine; Thymidine; Treatment Outcome | 2013 |
Serum hepatitis B surface antigen kinetics in severe reactivation of hepatitis B e antigen negative chronic hepatitis B patients receiving nucleoside/nucleotide analogues.
Topics: Adult; Aged; Alanine Transaminase; Antiviral Agents; DNA, Viral; Female; Guanine; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Nucleic Acid Synthesis Inhibitors; Recurrence; Reverse Transcriptase Inhibitors; Telbivudine; Thymidine; Viral Load; Young Adult | 2013 |
Durability of efficacy after telbivudine off-treatment in chronic hepatitis B patients.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Female; Follow-Up Studies; Hepatitis B, Chronic; Humans; Male; Middle Aged; Recurrence; Retrospective Studies; Telbivudine; Thymidine; Treatment Outcome; Young Adult | 2014 |
Telbivudine prophylaxis for hepatitis B virus recurrence after liver transplantation improves renal function.
Topics: Adult; Antiviral Agents; Creatinine; Female; Hepatitis B, Chronic; Humans; Lamivudine; Liver Transplantation; Male; Middle Aged; Recurrence; Telbivudine; Thymidine | 2014 |
Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy.
Topics: Aged; Antiviral Agents; Diabetes Mellitus; Drug Substitution; End Stage Liver Disease; Female; Glomerular Filtration Rate; Hepatitis B; Humans; Incidence; Kaplan-Meier Estimate; Kidney; Lamivudine; Liver Transplantation; Male; Middle Aged; Muscular Diseases; Polyneuropathies; Proportional Hazards Models; Prospective Studies; Recovery of Function; Recurrence; Renal Insufficiency, Chronic; Risk Factors; Telbivudine; Thymidine; Time Factors; Treatment Outcome; Turkey | 2015 |
Ten-year follow-up of hepatitis B relapse after cessation of lamivudine or telbivudine treatment in chronic hepatitis B patients.
Topics: Adolescent; Adult; Antiviral Agents; DNA, Viral; Feasibility Studies; Female; Follow-Up Studies; Hepacivirus; Hepatitis B Antigens; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Recurrence; Retrospective Studies; Telbivudine; Thymidine; Young Adult | 2015 |
Telbivudin as prophylaxis for hepatitis B virus recurrence after liver transplantation: a case series in single-center experience.
Topics: Adult; Case-Control Studies; Female; Hepatitis B; Humans; Liver Transplantation; Male; Middle Aged; Nucleosides; Pyrimidinones; Recurrence; Telbivudine; Thymidine; Viral Load | 2012 |